Using VIP as a prognostic marker of autoimmune diseases

摘要

Vip use as a prognostic marker of autoimmune diseases. # The present invention relates to the use of an expression product of VIP gene as a prognostic marker for an autoimmune disease, preferably autoimmune arthritis in patients previously diagnosed with said autoimmune disease. The invention is also directed to a method for the prognosis of an autoimmune disease, preferably autoimmune arthritis, which is characterized by determining the amount of an expression product of the VIP gene.